ArticleMolecules (Basel, Switzerland)2022
In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma.
Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Sucheewin Krobthong, Patompon Wongtrakoongate, Jittiyawadee Sripa, Panthip Rattanasinganchan, Pornphimon Metheenukul, Rutaiwan Tohtong
Open access · goldAbstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 4 institutions in 1 country.
Brinda BalasubramanianDepartment of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0003-4808-9748 Simran VenkatramanGraduate Program in Molecular Medicine, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0002-2037-0952 Kyaw Zwar MyintGraduate Program in Molecular Medicine, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Sucheewin KrobthongCenter for Neuroscience, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0003-4428-4140 Patompon WongtrakoongateDepartment of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0001-6070-1843 Jittiyawadee SripaCollege of Medicine and Public Health, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand.
Panthip RattanasinganchanFaculty of Medical Technology, Huachiew Chalermprakiet University, Samut Prakan 10540, Thailand.ORCID 0000-0002-8849-1590 Pornphimon MetheenukulDepartment of Veterinary Technology, Faculty of Veterinary Technology, Kasetsart University, Bangkok 10900, Thailand.ORCID 0000-0001-6020-2040 Rutaiwan TohtongDepartment of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0003-3670-1004 Mahidol University · THHuachiew Chalermprakiet University · THKasetsart University · THUbon Ratchathani University · TH
Funding
Mahidol University Basic Research Fund: fiscal year 2022
6 · The paper itselfAbstract
Cholangiocarcinoma (CCA) is a heterogenous group of malignancies in the bile duct, which proliferates aggressively. CCA is highly prevalent in Northeastern Thailand wherein it is associated with liver fluke infection, or
Indexed as
Bile Duct NeoplasmsCholangiocarcinomaOpisthorchiasisOpisthorchisAnimalsBile Ducts, IntrahepaticFlavonoidsHumansMatrix Metalloproteinase 9FlavonoidsgalanginMatrix Metalloproteinase 9anti-cancercholangiocarcinomaGalanginmolecular dockingproteomics
Identifiers
PMID35889537
PMCPMC9351686
OpenAlexW4286434144
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390